Calf hypertrophy and raised transaminases in a child: a case report of muscular dystrophy
DOI:
https://doi.org/10.32385/rpmgf.v30i6.11404Keywords:
Transaminases, Creatine Kinase, Muscular Dystrophy, Calf HypertrophyAbstract
Introduction: Transaminases are non-specific markers of hepatocyte function. There are several conditions associated with elevated transa-minases such as Duchenne muscular dystrophy (DMD), an X-linked recessive disorder characterized by progressive muscle weakness. Case Report: We report the case of a 6 year-old boy referred to the pediatric department for evaluation of raised transaminases. He had no family history of liver or neuromuscular disease. From his past history we noted independent gait at 15 months, toe-walking, difficulty climbing stairs and running, and fatigue in comparison to his peers. On clinical examination there was calf and abdominal hypertrophy, slight lumbar lordosis, proximal lower limb weakness and a positive Gowers’ sign. Given the clinical history, physical examination and la-boratory findings, the diagnosis of muscular dystrophy was suspected. Serum creatine kinase was found to be elevated. A muscle biopsy was performed and revealed absence of dystrophin. DMD gene sequencing identified the mutation c.3103C>T (p.Gln1035X) which confirmed the diagnosis of DMD. Comment: The finding of raised transaminases is not always diagnostic of liver disease. With prolonged elevation of those enzymes, liver disease must be excluded but this laboratory finding may also appear in muscle disease. CK levels should also be measured to avoid exhaustive testing for liver disease. The authors advise clinicians to consider neuromuscular diseases in the differential diagnosis of cases presenting a with suggestive clinical and laboratory findings.Downloads
Downloads
Published
Issue
Section
License
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.